JP2013534313A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013534313A5 JP2013534313A5 JP2013522346A JP2013522346A JP2013534313A5 JP 2013534313 A5 JP2013534313 A5 JP 2013534313A5 JP 2013522346 A JP2013522346 A JP 2013522346A JP 2013522346 A JP2013522346 A JP 2013522346A JP 2013534313 A5 JP2013534313 A5 JP 2013534313A5
- Authority
- JP
- Japan
- Prior art keywords
- hmgb1
- antibody
- stool sample
- protein
- ibd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2010A000442 | 2010-08-05 | ||
| ITRM2010A000442A IT1406051B1 (it) | 2010-08-05 | 2010-08-05 | Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo. |
| PCT/IT2011/000276 WO2012017466A1 (en) | 2010-08-05 | 2011-08-01 | Use of hmgb1 as' a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013534313A JP2013534313A (ja) | 2013-09-02 |
| JP2013534313A5 true JP2013534313A5 (enExample) | 2014-09-18 |
Family
ID=43739596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013522346A Pending JP2013534313A (ja) | 2010-08-05 | 2011-08-01 | 腸の炎症状態の生物学的マーカーとしてのｈｍｇｂ１の使用、糞便サンプル中のｈｍｇｂ１を検出するための非侵襲法およびそのキット |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20130137123A1 (enExample) |
| EP (1) | EP2601525A1 (enExample) |
| JP (1) | JP2013534313A (enExample) |
| CN (1) | CN103069276A (enExample) |
| AU (1) | AU2011287193B2 (enExample) |
| BR (1) | BR112013002145A2 (enExample) |
| CA (1) | CA2807107C (enExample) |
| CL (1) | CL2013000223A1 (enExample) |
| EA (1) | EA201390197A1 (enExample) |
| IL (1) | IL223845A (enExample) |
| IT (1) | IT1406051B1 (enExample) |
| MX (1) | MX2013001327A (enExample) |
| PE (1) | PE20131062A1 (enExample) |
| WO (1) | WO2012017466A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015067913A1 (en) | 2013-11-07 | 2015-05-14 | Diagnodus Limited | Biomarkers |
| KR102236829B1 (ko) | 2013-03-15 | 2021-04-07 | 프로타고니스트 테라퓨틱스, 인코포레이티드 | 헵시딘 유사체 및 이의 용도 |
| AU2015258863B2 (en) | 2014-05-16 | 2019-10-24 | Protagonist Therapeutics, Inc. | Alpha4beta7 integrin thioether peptide antagonists |
| AU2015289642B2 (en) | 2014-07-17 | 2021-02-25 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| WO2017117411A1 (en) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2018089693A2 (en) * | 2016-11-09 | 2018-05-17 | Protagonist Therapeutics, Inc. | Methods for determining and monitoring gastrointestinal inflammation |
| BR112019023772A2 (pt) | 2017-05-12 | 2020-06-09 | Evonik Operations Gmbh | método para detectar doenças induzidas por c. perfringens em animais e kit de diagnóstico |
| IT201700083055A1 (it) | 2017-07-20 | 2019-01-20 | Laura Stronati | “uso della proteina inibitore 2 della dissociazione di rho gdp come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” |
| IT201700083044A1 (it) | 2017-07-20 | 2019-01-20 | Laura Stronati | “uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” |
| EP3749345A4 (en) | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
| US20210011027A1 (en) * | 2018-03-02 | 2021-01-14 | Evonik Operations Gmbh | In vitro method for detecting intestinal barrier failure in animals by determining ovotransferrin |
| CN109030817A (zh) * | 2018-07-04 | 2018-12-18 | 长沙都正医学检验有限责任公司 | Hmgb1检测试剂盒及其制备方法 |
| TW202019948A (zh) | 2018-07-12 | 2020-06-01 | 美商領導醫療有限公司 | 介白素-23受體之肽抑制劑及其治療發炎疾病之用途 |
| MX2021006917A (es) | 2018-12-14 | 2021-07-07 | Evonik Operations Gmbh | Procedimiento in vitro para la deteccion de disbiosis intestinal aviar. |
| US11684653B2 (en) * | 2019-03-06 | 2023-06-27 | The Cleveland Clinic Foundation | Compositions and method for reducing virulence of microorganisms |
| CN118063554A (zh) | 2020-01-15 | 2024-05-24 | 詹森生物科技公司 | 介白素-23受体的肽抑制剂及其治疗炎性疾病的用途 |
| KR20220141808A (ko) | 2020-01-15 | 2022-10-20 | 얀센 바이오테크 인코포레이티드 | 인터루킨-23 수용체의 펩티드 억제제 및 염증성 질환을 치료하기 위한 이의 용도 |
| KR20230110570A (ko) | 2020-11-20 | 2023-07-24 | 얀센 파마슈티카 엔.브이. | 인터류킨-23 수용체의 펩티드 억제제의 조성물 |
| TW202330013A (zh) | 2021-07-14 | 2023-08-01 | 美商健生生物科技公司 | 介白素－２３受體之脂化肽抑制劑 |
| CN116973572B (zh) * | 2023-06-02 | 2025-03-07 | 东南大学附属中大医院 | 基于血、粪便铁蛋白检测评估肠屏障损伤严重程度的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1577671A1 (en) * | 1996-07-17 | 2005-09-21 | Kaneka Corporation | Diagnostic drugs for autoimmune diseases |
| US6355623B2 (en) * | 1998-09-24 | 2002-03-12 | Hopital-Sainte-Justine | Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage |
| US6303321B1 (en) * | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
| US7700307B2 (en) * | 2003-03-08 | 2010-04-20 | Auvation Limited | Mitochondrial stress-70 protein markers for colorectal cancer |
| CN101132811B (zh) * | 2004-10-22 | 2012-05-30 | 米迪缪尼有限公司 | 抗hmgb1的高亲和力抗体及其用法 |
| WO2008075788A1 (ja) * | 2006-12-20 | 2008-06-26 | Shino-Test Corporation | ヒトｈｍｇｂ１と特異的に結合する鳥類由来の抗体、ヒトｈｍｇｂ１の免疫学的測定方法及びヒトｈｍｇｂ１の免疫学的測定試薬 |
| AU2008283077A1 (en) * | 2007-08-02 | 2009-02-05 | Ith Immune Therapy Holdings Ab | Diagnosis, staging and monitoring of inflammatory bowel disease |
| JP2011514162A (ja) * | 2008-03-14 | 2011-05-06 | エグザジェン ダイアグノスティクス インコーポレイテッド | 炎症性腸疾患および過敏性腸症候群のバイオマーカー |
-
2010
- 2010-08-05 IT ITRM2010A000442A patent/IT1406051B1/it active
-
2011
- 2011-08-01 MX MX2013001327A patent/MX2013001327A/es unknown
- 2011-08-01 AU AU2011287193A patent/AU2011287193B2/en not_active Ceased
- 2011-08-01 EA EA201390197A patent/EA201390197A1/ru unknown
- 2011-08-01 CN CN2011800327624A patent/CN103069276A/zh active Pending
- 2011-08-01 EP EP11754539.2A patent/EP2601525A1/en not_active Withdrawn
- 2011-08-01 US US13/814,294 patent/US20130137123A1/en not_active Abandoned
- 2011-08-01 CA CA2807107A patent/CA2807107C/en not_active Expired - Fee Related
- 2011-08-01 BR BR112013002145A patent/BR112013002145A2/pt not_active IP Right Cessation
- 2011-08-01 WO PCT/IT2011/000276 patent/WO2012017466A1/en not_active Ceased
- 2011-08-01 PE PE2013000131A patent/PE20131062A1/es not_active Application Discontinuation
- 2011-08-01 JP JP2013522346A patent/JP2013534313A/ja active Pending
-
2012
- 2012-12-24 IL IL223845A patent/IL223845A/en active IP Right Grant
-
2013
- 2013-01-23 CL CL2013000223A patent/CL2013000223A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022077613A1 (zh) | 一种新型冠状病毒 s 蛋白的 b 细胞线性抗原表位、抗体、鉴定方法及应用 | |
| JP2013534313A (ja) | 腸の炎症状態の生物学的マーカーとしてのｈｍｇｂ１の使用、糞便サンプル中のｈｍｇｂ１を検出するための非侵襲法およびそのキット | |
| Muralidharan et al. | Development of an enzyme-linked immunosorbent assay for detecting Campylobacter hepaticus specific antibodies in chicken sera–a key tool in Spotty Liver Disease screening and vaccine development | |
| JPWO2008035527A1 (ja) | 抗Ｃ１ｑモノクローナル抗体 | |
| US20200172586A1 (en) | Novel proteins and detection methods | |
| CN110476065B (zh) | 诊断法 | |
| US12352766B2 (en) | Immunoassay method for free aim in biological sample, and method for detecting NASH in subject | |
| Cooper et al. | ELISA and immuno–polymerase chain reaction assays for the sensitive detection of melioidosis | |
| JP5204036B2 (ja) | 肺炎球菌の検出方法 | |
| Jeong et al. | Monoclonal antibodies to recombinant Der f 2 and development of a two‐site ELISA sensitive to major Der f 2 isoallergen in Korea | |
| EP2913675B1 (en) | GP2 isoforms and their use in autoantibody capture | |
| TW201403068A (zh) | 黑色素瘤的診斷套組 | |
| CN103421747B (zh) | 分泌牛il-4单克隆抗体的杂交瘤细胞株、其单克隆抗体及其应用 | |
| FR2966461A1 (fr) | Utilisation d'anticorps anti-vp2 du btv-8 pour le serotypage et le diagnostic des infections a btv | |
| Mohanty et al. | Development of recombinant NS1-NS3 antigen based indirect ELISA for detection of bluetongue antibodies in sheep | |
| WO2020245663A1 (en) | Nanobody-based ns1 assay for the specific diagnosis of acute zika virus infection | |
| CN111378628A (zh) | 一种分泌结核分枝杆菌esat6蛋白特异性抗体的杂交瘤细胞株、其抗体及应用 | |
| Pandey et al. | Antigen detection assay with parasite specific monoclonal antibodies for diagnosis of lymphatic filariasis | |
| Saenger et al. | Development of a surface display ELISA to detect anti-IgG antibodies against bovine αS1-casein in human sera | |
| Kalyan et al. | Antibody response to mycobacterial Rpf B protein and its immunodominant peptides in HIV-TB co-infected individuals | |
| CN101654668B (zh) | 杂交瘤细胞株及其产生抗广州管圆线虫v期幼虫55kd抗原单克隆抗体 | |
| US20220390449A1 (en) | New serological marker for the latent form of toxoplasmosis | |
| Wu et al. | Serum IgG Response to a Conserved Domain of Commensal Flagellins Predicts Future Risk of Crohn’s Disease in First-degree Relatives | |
| Zhang et al. | Soluble expression and purification of Brucella cell surface protein (BCSP31) of Brucella melitensis and preparation of anti-BCSP31 monoclonal antibodies | |
| CN109884310A (zh) | 肠道菌外膜多肽、抗体捕获器件及试剂盒 |